Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation-Reference-Cited by-同舟云学术

Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation

Published:2015-06-02 Issue:4 Volume:7 Page:672-680
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

van den Bremer Ewald TJ,Beurskens Frank J,Voorhorst Marleen,Engelberts Patrick J,de Jong Rob N,van der Boom Burt G,Cook Erika M,Lindorfer Margaret A,Taylor Ronald P,van Berkel Patrick HC,Parren Paul WHI

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1046665

Reference41 articles.

1. Strategies and challenges for the next generation of therapeutic antibodies

2. Development trends for human monoclonal antibody therapeutics

3. Antibody therapy of cancer

4. Antibody Therapeutics in Cancer

5. In vitro and in vivo modifications of recombinant and human IgG antibodies

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic capillary electrophoresis - mass spectrometry for rapid charge-variant and glycoform assessment of monoclonal antibody biosimilar candidates;Journal of Pharmaceutical and Biomedical Analysis;2024-09

2. Characterization of the Antibody Response to SARS-CoV-2 Infection in COVID-19 Transplant versus Nontransplant Recipients by Ig-MS;Journal of Proteome Research;2024-08-15

3. Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies;Frontiers in Immunology;2024-07-22

4. Fc proteoforms of ACPA IgG discriminate autoimmune responses in plasma and synovial fluid of rheumatoid arthritis patients and associate with disease activity;2024-04-06

5. Impact of structural modifications of IgG antibodies on effector functions;Frontiers in Immunology;2024-01-08